P388: PREFERENTIAL SYNERGISTIC EFFECT OF INDISULAM IN COMBINATION WITH VENETOCLAX AND AZACYTIDINE IN AML CELLS WITH SF3B1 MUTATIONS.

Bibliographic Details
Main Authors: P. Bernardo, M. Pereira, B. Galvão, J. Desterro, A. Nunes, M. D. J. Frade, J. Lobato, M. G. da Silva, M. Lemos, M. Silva, P. Ribeiro, S. Matos, N. Custódio, M. Carmo-Fonseca
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000844440.63033.80
_version_ 1797281785401311232
author P. Bernardo
M. Pereira
B. Galvão
J. Desterro
A. Nunes
M. D. J. Frade
J. Lobato
M. G. da Silva
M. Lemos
M. Silva
P. Ribeiro
S. Matos
N. Custódio
M. Carmo-Fonseca
author_facet P. Bernardo
M. Pereira
B. Galvão
J. Desterro
A. Nunes
M. D. J. Frade
J. Lobato
M. G. da Silva
M. Lemos
M. Silva
P. Ribeiro
S. Matos
N. Custódio
M. Carmo-Fonseca
author_sort P. Bernardo
collection DOAJ
first_indexed 2024-03-07T17:02:27Z
format Article
id doaj.art-f28f5b23678342969297c72a5220bca7
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T17:02:27Z
publishDate 2022-06-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-f28f5b23678342969297c72a5220bca72024-03-03T03:19:23ZengWileyHemaSphere2572-92412022-06-01628828910.1097/01.HS9.0000844440.63033.80202206003-00288P388: PREFERENTIAL SYNERGISTIC EFFECT OF INDISULAM IN COMBINATION WITH VENETOCLAX AND AZACYTIDINE IN AML CELLS WITH SF3B1 MUTATIONS.P. Bernardo0M. Pereira1B. Galvão2J. Desterro3A. Nunes4M. D. J. Frade5J. Lobato6M. G. da Silva7M. Lemos8M. Silva9P. Ribeiro10S. Matos11N. Custódio12M. Carmo-Fonseca131 Instituto Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa1 Instituto Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa1 Instituto Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa1 Instituto Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa3 Serviço de Hematologia Clínica, Instituto Português de Oncologia de Lisboa Francisco Gentil3 Serviço de Hematologia Clínica, Instituto Português de Oncologia de Lisboa Francisco Gentil3 Serviço de Hematologia Clínica, Instituto Português de Oncologia de Lisboa Francisco Gentil3 Serviço de Hematologia Clínica, Instituto Português de Oncologia de Lisboa Francisco Gentil4 Serviço de Hematologia Clínica, Centro Hospitalar Lisboa Central - Hospital de St. António dos Capuchos4 Serviço de Hematologia Clínica, Centro Hospitalar Lisboa Central - Hospital de St. António dos Capuchos4 Serviço de Hematologia Clínica, Centro Hospitalar Lisboa Central - Hospital de St. António dos Capuchos5 GenoMed - Diagnósticos de Medicina Molecular SA, Lisbon, Portugal1 Instituto Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa1 Instituto Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboahttp://journals.lww.com/10.1097/01.HS9.0000844440.63033.80
spellingShingle P. Bernardo
M. Pereira
B. Galvão
J. Desterro
A. Nunes
M. D. J. Frade
J. Lobato
M. G. da Silva
M. Lemos
M. Silva
P. Ribeiro
S. Matos
N. Custódio
M. Carmo-Fonseca
P388: PREFERENTIAL SYNERGISTIC EFFECT OF INDISULAM IN COMBINATION WITH VENETOCLAX AND AZACYTIDINE IN AML CELLS WITH SF3B1 MUTATIONS.
HemaSphere
title P388: PREFERENTIAL SYNERGISTIC EFFECT OF INDISULAM IN COMBINATION WITH VENETOCLAX AND AZACYTIDINE IN AML CELLS WITH SF3B1 MUTATIONS.
title_full P388: PREFERENTIAL SYNERGISTIC EFFECT OF INDISULAM IN COMBINATION WITH VENETOCLAX AND AZACYTIDINE IN AML CELLS WITH SF3B1 MUTATIONS.
title_fullStr P388: PREFERENTIAL SYNERGISTIC EFFECT OF INDISULAM IN COMBINATION WITH VENETOCLAX AND AZACYTIDINE IN AML CELLS WITH SF3B1 MUTATIONS.
title_full_unstemmed P388: PREFERENTIAL SYNERGISTIC EFFECT OF INDISULAM IN COMBINATION WITH VENETOCLAX AND AZACYTIDINE IN AML CELLS WITH SF3B1 MUTATIONS.
title_short P388: PREFERENTIAL SYNERGISTIC EFFECT OF INDISULAM IN COMBINATION WITH VENETOCLAX AND AZACYTIDINE IN AML CELLS WITH SF3B1 MUTATIONS.
title_sort p388 preferential synergistic effect of indisulam in combination with venetoclax and azacytidine in aml cells with sf3b1 mutations
url http://journals.lww.com/10.1097/01.HS9.0000844440.63033.80
work_keys_str_mv AT pbernardo p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations
AT mpereira p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations
AT bgalvao p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations
AT jdesterro p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations
AT anunes p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations
AT mdjfrade p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations
AT jlobato p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations
AT mgdasilva p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations
AT mlemos p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations
AT msilva p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations
AT pribeiro p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations
AT smatos p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations
AT ncustodio p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations
AT mcarmofonseca p388preferentialsynergisticeffectofindisulamincombinationwithvenetoclaxandazacytidineinamlcellswithsf3b1mutations